Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)
April 10 2023 - 7:15AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 6-K
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of April 2023
Commission File Number: 001-40997
Bright Minds Biosciences Inc.
(Translation of registrant's name into English)
19 Vestry Street
New York, NY 10013
(Address of principal executive office)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F
Form 20-F [ X ] Form 40-F [ ]
SUBMITTED HEREWITH
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| | Bright Minds Biosciences Inc. |
| | |
| | |
| | |
Date: April 10, 2023 | | /s/ Ryan Cheung |
| | Ryan Cheung |
| | Chief Financial Officer |
| | |
Bright Minds Biosciences (NASDAQ:DRUG)
Historical Stock Chart
From May 2024 to Jun 2024
Bright Minds Biosciences (NASDAQ:DRUG)
Historical Stock Chart
From Jun 2023 to Jun 2024